January 2026
The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy
Breakthrough in laboratory sterilisation: Azenta unveils revolutionary electron-beam tube technology
, /in Product News /by panglobalAzenta Life Sciences has achieved a significant milestone in sterile sample storage with the launch of advanced electron-beam (E-beam) treated tubes, marking a major shift towards chemical-free sterilisation in clinical and research laboratories. This breakthrough technology addresses critical contamination challenges whilst delivering unprecedented surface treatment uniformity.
TQ Therapeutics secures strategic acquisition to accelerate automated cell therapy breakthrough
, /in E-News /by panglobalGerman biotechnology firm TQ Therapeutics GmbH has strategically acquired Juno Therapeutics GmbH, dramatically expanding capabilities for developing next-generation ultra-short extracorporeal cell and gene therapy systems that could transform patient access to personalised cellular treatments.
Tagomics secures £860k grant to advance colorectal cancer detection platform
, /in E-News /by panglobalTagomics Ltd has secured £860,000 in Innovate UK Biomedical Catalyst funding to develop a sophisticated diagnostic test for early colorectal cancer detection, forming part of a £1.2 million project that could transform cancer screening capabilities. The Cambridge-based biomarker discovery company will customise its proprietary Interlace platform to identify genetic and epigenetic mutations associated with colorectal […]
Roche partners with Broad Clinical Labs for neonatal genome sequencing initiative
, /in E-News /by panglobalRoche has announced a strategic collaboration with Broad Clinical Labs to develop clinical applications for its Sequencing by Expansion (SBX) technology, with an initial focus on whole genome sequencing for critically ill newborns and their biological parents. The partnership aims to establish genomic sequencing as routine clinical practice in neonatal intensive care units.
SpliceBio breaks gene therapy packaging barriers with US$135 million Series B funding
, /in E-News /by panglobalSpliceBio has secured US$135 million in Series B funding to tackle one of gene therapy’s most persistent technical barriers: the packaging capacity limitations that have rendered many genetic diseases untreatable. The Barcelona-based company’s breakthrough protein splicing technology promises to unlock therapeutic potential for conditions caused by genes too large for conventional delivery systems.
Enterome secures $19 million funding to advance lymphoma immunotherapy
, /in E-News /by panglobalFrench clinical-stage biotechnology company Enterome SA has raised US$19 million in private financing to advance its lead OncoMimics™ immunotherapy candidate EO2463 for treating indolent non-Hodgkin lymphoma, with particular focus on patients in the “watch-and-wait” category who currently lack approved treatment options.
osteolabs partners with Swiss laboratory to deploy calcium isotope breakthrough
, /in E-News /by panglobalGerman biotech company osteolabs GmbH has secured a pivotal distribution partnership with leading Swiss medical laboratory ‘labor team’, bringing cutting-edge calcium isotope technology to Switzerland and Liechtenstein’s healthcare systems and with the aim of transforming bone health diagnostics for over half a million patients.
Biogen partners with City Therapeutics in $46 million RNAi collaboration targeting CNS disorders
, /in E-News /by panglobalBiotechnology giant Biogen has entered into a strategic research partnership with privately held City Therapeutics to develop novel RNA interference-based therapeutics for central nervous system diseases, combining next-generation RNAi engineering with proprietary drug delivery technologies.
Roche announces US$50 billion US expansion targeting gene therapy and AI research capabilities
, /in E-News /by panglobalF. Hoffmann-La Roche has announced an ambitious US$50 billion investment initiative spanning five years, designed to transform the company’s United States pharmaceutical and diagnostics infrastructure. The comprehensive expansion programme addresses critical manufacturing bottlenecks whilst establishing cutting-edge research capabilities across multiple therapeutic domains, creating over 12,000 new positions in the biomedical technology sector.
INTEGRA automation breakthrough transforms cellular transporter drug discovery
, /in E-News /by panglobalAustrian biotech Solgate has achieved a significant milestone in pharmaceutical research by deploying precision automated liquid handling systems to unlock therapeutic potential in solute carrier transporters, targeting one of medicine’s most underexplored protein families that orchestrate cellular traffic and drive diverse disease mechanisms.